Annual report pursuant to Section 13 and 15(d)

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

v3.19.3
SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS
 12 Months Ended
Jul. 31, 2019
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]

ENZO BIOCHEM, INC
SCHEDULE II


VALUATION AND QUALIFYING ACCOUNTS
As of and for the Years ended July 31, 2019, 2018 and 2017


(in thousands)


Year ended
July 31,		   Description   Balance at
Beginning
of Year		     Charged
(credited) to costs
and expenses		     Charged
to other
accounts		     Deductions     Balance at
end of Year		  
                                             
2019   Allowance for doubtful accounts receivable     145       42               21 (1)     166  
                                             
2018   Allowance for doubtful accounts receivable     147       —               2 (1)     145  
                                             
2017   Allowance for doubtful accounts receivable     102       57               12 (1)     147  
                                             
2019   Deferred tax valuation allowance     24,471       (944 )                     23,527  
                                             
2018   Deferred tax valuation allowance     32,581       (8,110 )                     24,471  
                                             
2017   Deferred tax valuation allowance     34,912       (2,331 )                     32,581  

   
(1) Write-off of uncollectible accounts receivable.